These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15389729)

  • 1. Fighting tuberculosis: an old disease with new challenges.
    Tripathi RP; Tewari N; Dwivedi N; Tiwari VK
    Med Res Rev; 2005 Jan; 25(1):93-131. PubMed ID: 15389729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tuberculosis - historical development, current status, future prospects].
    Loddenkemper R; Diel R; Schaberg T
    Pneumologie; 2010 Sep; 64(9):567-72. PubMed ID: 20827640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of tuberculosis: present status and future prospects.
    Onyebujoh P; Zumla A; Ribeiro I; Rustomjee R; Mwaba P; Gomes M; Grange JM
    Bull World Health Organ; 2005 Nov; 83(11):857-65. PubMed ID: 16302043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkaloids as potential anti-tubercular agents.
    Kishore N; Mishra BB; Tripathi V; Tiwari VK
    Fitoterapia; 2009 Apr; 80(3):149-63. PubMed ID: 19344681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing TB in the 21st century: existing and novel drug therapies.
    Guy ES; Mallampalli A
    Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach.
    Biava M; Porretta GC; Poce G; Battilocchio C; Alfonso S; de Logu A; Manetti F; Botta M
    ChemMedChem; 2011 Apr; 6(4):593-9. PubMed ID: 21341373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
    Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
    PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery.
    Sosnik A; Carcaboso AM; Glisoni RJ; Moretton MA; Chiappetta DA
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):547-59. PubMed ID: 19914315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis, a re-emergent disease.
    Valadas E; Antunes F
    Eur J Radiol; 2005 Aug; 55(2):154-7. PubMed ID: 15905058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging drugs for active tuberculosis.
    Ginsberg AM
    Semin Respir Crit Care Med; 2008 Oct; 29(5):552-9. PubMed ID: 18810688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for new tuberculosis treatment in Africa.
    Mwinga A; Bernard Fourie P
    Trop Med Int Health; 2004 Jul; 9(7):827-32. PubMed ID: 15228494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis.
    Sacchettini JC; Rubin EJ; Freundlich JS
    Nat Rev Microbiol; 2008 Jan; 6(1):41-52. PubMed ID: 18079742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis.
    Anishetty S; Pulimi M; Pennathur G
    Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategies in fighting TB: targeting Mycobacterium tuberculosis-secreted phosphatases MptpA & MptpB.
    Silva AP; Tabernero L
    Future Med Chem; 2010 Aug; 2(8):1325-37. PubMed ID: 21426021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global alliance for tuberculosis drug development--accomplishments and future directions.
    Gardner CA; Acharya T; Pablos-Méndez A
    Clin Chest Med; 2005 Jun; 26(2):341-7, vii. PubMed ID: 15837115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global epidemiology of tuberculosis: prospects for control.
    Lönnroth K; Raviglione M
    Semin Respir Crit Care Med; 2008 Oct; 29(5):481-91. PubMed ID: 18810682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives on natural products in TB drug research.
    Pauli GF; Case RJ; Inui T; Wang Y; Cho S; Fischer NH; Franzblau SG
    Life Sci; 2005 Dec; 78(5):485-94. PubMed ID: 16243360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.